Home
/
HOOKIPA Pharma Inc.
/
Financials
/
Quarterly
HOOKIPA Pharma Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HOOKIPA Pharma Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Mar 31, 2025
$2.00M
May 15, 2025
Q3
2024
Sep 30, 2024
$4.70M
Nov 14, 2024
Q2
2024
Jun 30, 2024
$1.29M
Aug 8, 2024
Q1
2025
Mar 31, 2024
$36.60M
May 15, 2025
Q3
2024
Sep 30, 2023
$6.87M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$2.68M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$3.18M
May 9, 2024
Q3
2023
Sep 30, 2022
$2.23M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$2.75M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$1.45M
May 11, 2023
Q3
2022
Sep 30, 2021
$3.87M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$5.38M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$5.30M
May 16, 2022
Q3
2021
Sep 30, 2020
$4.04M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$6.69M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$3.70M
May 12, 2021
Q3
2020
Sep 30, 2019
$2.04M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$4.05M
Aug 13, 2020
Q1
2020
Mar 31, 2019
$2.24M
May 14, 2020
Q3
2019
Sep 30, 2018
$1.90M
Nov 12, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Mar 31, 2025
($15.43M)
May 15, 2025
Q1
2025
Dec 31, 2024
($43.50M)
May 15, 2025
Q3
2024
Sep 30, 2024
($13.84M)
Nov 14, 2024
Q2
2024
Jun 30, 2024
($19.10M)
Aug 8, 2024
Q3
2024
Jun 30, 2024
($19.10M)
Nov 14, 2024
Q2
2024
Mar 31, 2024
$14.38M
Aug 8, 2024
Q3
2024
Mar 31, 2024
$14.38M
Nov 14, 2024
Q1
2025
Mar 31, 2024
$14.38M
May 15, 2025
Q1
2024
Dec 31, 2023
($81.60M)
May 9, 2024
Q3
2024
Dec 31, 2023
($81.60M)
Nov 14, 2024
Q2
2024
Dec 31, 2023
($81.60M)
Aug 8, 2024
Q3
2024
Sep 30, 2023
($19.07M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($18.02M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($18.02M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($19.68M)
May 9, 2024
Q2
2024
Mar 31, 2023
($19.68M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($19.68M)
Nov 14, 2024
Q1
2023
Dec 31, 2022
($64.90M)
May 11, 2023
Q2
2023
Dec 31, 2022
($64.90M)
Aug 10, 2023
Q3
2023
Dec 31, 2022
($64.90M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Mar 31, 2025
($17.87M)
May 15, 2025
Q3
2024
Sep 30, 2024
($18.64M)
Nov 14, 2024
Q2
2024
Jun 30, 2024
($22.46M)
Aug 8, 2024
Q1
2025
Mar 31, 2024
$11.11M
May 15, 2025
Q3
2024
Sep 30, 2023
($22.67M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($21.47M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($22.66M)
May 9, 2024
Q3
2023
Sep 30, 2022
($20.99M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($18.43M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($20.15M)
May 11, 2023
Q3
2022
Sep 30, 2021
($21.17M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($19.29M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($19.17M)
May 16, 2022
Q3
2021
Sep 30, 2020
($16.41M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($9.23M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($12.46M)
May 12, 2021
Q3
2020
Sep 30, 2019
($13.58M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($13.63M)
Aug 13, 2020
Q1
2020
Mar 31, 2019
($10.66M)
May 14, 2020
Q3
2019
Sep 30, 2018
($5.55M)
Nov 12, 2019